SQ Innovation will use Ligand’s Captisol technology to achieve a smaller delivery volume for more cost-effective diuretic treatment in heart failure.
Lasix ONYU is not approved for sale.
Lasix ONYU is not approved for sale.
SQ Innovation will use Ligand’s Captisol technology to achieve a smaller delivery volume for more cost-effective diuretic treatment in heart failure.
Sign up for our email list below to receive periodic updates from SQ Innovation, Inc. on the Lasix SQF Infusion as we continue development and go to market.